山大地緯(688579.SH):山東大學籌劃深化校屬企業體制改革
格隆匯4月10日丨山大地緯(688579.SH)公佈,公司於2025年4月10日收到公司控股股東山東山大資本運營有限公司(以下簡稱“資本運營公司”)的告知函,依據國家關於高校所屬企業體制改革政策要求,山東大學正在籌劃深化校屬企業體制改革事宜,該事項可能導致公司控股股東、實際控制人發生變動。目前該事項尚處於籌劃階段,存在不確定性。
截止本公告披露日,資本運營公司持有公司118,342,400股股份,佔公司總股本比例爲29.58%。資本運營公司爲山東大學下屬國有獨資企業。公司目前控股股東爲資本運營公司,實際控制人爲山東大學。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.